Pacer Advisors’s Alpine Immune Sciences Inc ALPN Stock Holding History

Pacer Advisors’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,095	Closed	-$43.4K	–	3804
2024 Q1	$43.4K	Buy	+1,095	New	+$32.3K	﹤0.01%	3227

Pacer Advisors's ALPN Position: Q2 2024 in Review

Pacer Advisors sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 1,095 shares — an estimated $43.4K sold.

Pacer Advisors first reported a position in ALPN in Q1 2024 and held it in 1 quarter. The position peaked at $43.4K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Pacer Advisors reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Pacer Advisors sold 1,095 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $43.4K.
Pacer Advisors first reported a position in Alpine Immune Sciences Inc in Q1 2024 and held it in 1 quarter.
Pacer Advisors's Alpine Immune Sciences Inc position peaked at $43.4K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Pacer Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.